Our “Multi-Bagger” Portfolio Outpaced the S&P 500 In March

The munKNEE “Multi-bagger” Portfolio consists of 9 cannabis, psychedelic and plant-based food stocks with market capitalizations between $75M and $399M – an average of only $122M in comparison to the munKNEE “Rags-to-Riches” Portfolio which consists of 16 stocks in the same four categories but with market capitalizations between $400M and $3.0B – averaging $968M.

An original article by Lorimer Wilson, Managing Editor of munKNEE.com (Your KEY To Making Money!)

Here’s an update on how the various categories in the Portfolio, and their constituents, performed in March and have performed YTD.

1. American Cannabis MSO constituents:
   • Ascend (AAWH): DOWN 18.8% in March; DOWN 26.9% YTD;
   • Jushi (JUSHF): DOWN 18.8% in March; DOWN 29.7% YTD; and
   • Planet 13 (PLNHF): DOWN 11.4% in March; UP 13.0% YTD.
     • DOWN 16.4% in March; DOWN 17.6% YTD.
   • Wall Street analysts have an average 12-month price target for the above stocks representing a 210% increase from its March 31st price,
   • For comparison purposes, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) was DOWN 13.1% in March and is now DOWN 18.6% YTD.
2. Canadian Cannabis LP constituents:
   • Aurora (ACB): DOWN 16.7% in March; DOWN 21.3% YTD; and
   • Organigram (OGI): DOWN 19.0% in March; DOWN 17.9% YTD.
     • DOWN 17.8% in March; DOWN 19.8% YTD;
   • Wall Street analysts have an average 12-month price target for the above stocks representing a 119% increase from its March 31st price,
   • For comparison purposes, the Global X Cannabis ETF (POTX) was DOWN 15.0% in March; DOWN 18.3% YTD;.
3. Psychedelic Drug Stock constituents:
   • Cybin (CYBN): DOWN 25.0% in March; UP 34.5% YTD;
   • Mind Medicine (MNMD): DOWN 14.8% in March; UP 48.8% YTD; and
   • Seelos Therapeutics (SEEL): DOWN 12.7% in March; UP 6.2% YTD.
     • DOWN 15.5% in March; UP 36.2% YTD.
   • Wall Street analysts have an average 12-month price target for the above stocks representing a 690% increase from its March 31st price,
   • For comparison purposes, the AdvisorShares Psychedelics ETF (PSIL) was DOWN 11.3% in March; UP 1.1% YTD.
4. Plant-Based Food Stock constituent:
   • Tattooed Chef (TTCF): UP 12.7% in March; UP 14.5% YTD.
     • UP 12.7% in March; UP 14.5% YTD.
   • Wall Street analysts have an average 12-month price target for the above stocks representing a 53% increase from its March 31st price,
   • No comparable plant-based food stock ETFs.

The munKNEE “Multi-bagger” Portfolio was:

• UP 5.7% in March but is still DOWN 12.7% YTD;
• In comparison, our munKNEE “Rags-to-Riches” Portfolio was DOWN 8.6% in March and is DOWN 3.9% YTD;
• while the S&P 500 which was UP 5.2% in March and is UP 7.0% YTD; and
• Wall Street analysts have a 12-month price target for the above stocks representing an average 393% increase from its March 31st price.

Read More